NYSE:RMEDRA Medical Systems Stock Price, Forecast & News

$0.53

+0.04 (+8.13 %)

(As of 05/26/2020 04:00 PM ET)

Add

Compare

Today's Range

$0.50

Now: $0.53▼

$0.59

50-Day Range

$0.48

MA: $0.98▼

$1.26

52-Week Range

$0.35

Now: $0.53▼

$4.25

Volume12.45 million shs

Average Volume3.61 million shs

Market Capitalization$7.39 million

P/E RatioN/A

Dividend YieldN/A

Beta1.48

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

Beat the Market (BTM) Rank^™

3.1 Analyst's Opinion

Consensus Rating
RA Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $1.75, RA Medical Systems has a potential upside of 227.2% from its current price of $0.53.
Amount of Analyst Coverage
RA Medical Systems has only been the subject of 3 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
RA Medical Systems has received 73 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
RA Medical Systems has received 104 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
RA Medical Systems has received 58.76% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about RA Medical Systems and other stocks. Vote “Outperform” if you believe RMED will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RMED will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
RA Medical Systems does not currently pay a dividend.
Dividend Growth
RA Medical Systems does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, RA Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $45,732.00 in company stock.
Percentage Held by Insiders
Only 25.20% of the stock of RA Medical Systems is held by insiders.
Percentage Held by Institutions
Only 14.44% of the stock of RA Medical Systems is held by institutions.

1.3 Earnings and Valuation

Earnings Growth
Earnings for RA Medical Systems are expected to grow in the coming year, from ($1.06) to ($0.68) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of RA Medical Systems is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of RA Medical Systems is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
RA Medical Systems has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.30 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolNYSE:RMED

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.ramed.com

Phone760-804-1648

Debt

Debt-to-Equity Ratio0.10

Current Ratio4.76

Quick Ratio4.30

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$7.20 million

Price / Sales1.03

Cash FlowN/A

Price / Cash FlowN/A

Book Value$2.47 per share

Price / Book0.22

Profitability

EPS (Most Recent Fiscal Year)($4.33)

Net Income$-56,960,000.00

Net Margins-732.37%

Return on Equity-130.46%

Return on Assets-101.56%

Miscellaneous

Employees95

Outstanding Shares13,900,000

Market Cap$7.39 million

Next Earnings Date11/25/2020 (Estimated)

OptionableNot Optionable

Receive RMED News and Ratings via Email

Sign-up to receive the latest news and ratings for RMED and its competitors with MarketBeat's FREE daily newsletter.

RA Medical Systems (NYSE:RMED) Frequently Asked Questions

How has RA Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

RA Medical Systems' stock was trading at $1.2563 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, RMED shares have decreased by 57.4% and is now trading at $0.5349. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of RA Medical Systems?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RA Medical Systems in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for RA Medical Systems.

When is RA Medical Systems' next earnings date?

RA Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, November 25th 2020. View our earnings forecast for RA Medical Systems.

How were RA Medical Systems' earnings last quarter?

RA Medical Systems Inc (NYSE:RMED) announced its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.22. The business had revenue of $1.37 million for the quarter, compared to analyst estimates of $1.51 million. RA Medical Systems had a negative return on equity of 130.46% and a negative net margin of 732.37%. View RA Medical Systems' earnings history.

What price target have analysts set for RMED?

4 brokerages have issued 1 year price objectives for RA Medical Systems' shares. Their forecasts range from $1.00 to $3.00. On average, they expect RA Medical Systems' share price to reach $1.75 in the next twelve months. This suggests a possible upside of 227.2% from the stock's current price. View analysts' price targets for RA Medical Systems.

Has RA Medical Systems been receiving favorable news coverage?

News articles about RMED stock have trended extremely negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. RA Medical Systems earned a daily sentiment score of -5.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutRA Medical Systems.

Are investors shorting RA Medical Systems?

RA Medical Systems saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 196,700 shares, an increase of 108.1% from the April 30th total of 94,500 shares. Based on an average trading volume of 104,900 shares, the days-to-cover ratio is presently 1.9 days. Approximately 2.4% of the company's stock are short sold. View RA Medical Systems' Current Options Chain.

Who are some of RA Medical Systems' key competitors?

Some companies that are related to RA Medical Systems include DarioHealth (DRIO), Biostage (BSTG), Atossa Genetics (ATOS), Interpace Diagnostics Group (IDXG), Titan Medical (TMDI), Endologix (ELGX), Avinger (AVGR), Dynatronics (DYNT), Sintx Technologies (SINT), Lianluo Smart (LLIT), Invivo Therapeutics (NVIV), Encision (ECIA), PlusTherapeuticsInc . (PSTV), Hancock Jaffe Laboratories (HJLI) and CELLECT BIOTECH/S (APOP). View all competitors.

What other stocks do shareholders of RA Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RA Medical Systems investors own include Corbus Pharmaceuticals (CRBP), Vaxart (VXRT), Amarin (AMRN), Co-Diagnostics (CODX), Inovio Pharmaceuticals (INO), Agile Therapeutics (AGRX), Nabriva Therapeutics (NBRV), VBI Vaccines (VBIV), vTv Therapeutics (VTVT) and Advanced Micro Devices (AMD).

Who are RA Medical Systems' key executives?

RA Medical Systems' management team includes the following people:

Mr. Dean Irwin, CEO, Chief Technology Officer & Chairman of Director (Age 56)
Mr. Jeffrey Jay Kraws, Pres (Age 55)
Ms. Melissa Burstein, Exec. VP & Director (Age 43)
Mr. Richard Heymann, Director of Corp. Strategy & Bus. Devel. (Age 64)
Mr. Andrew C. Jackson, Chief Financial Officer (Age 50)

When did RA Medical Systems IPO?

(RMED) raised $50 million in an IPO on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is RA Medical Systems' stock symbol?

RA Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

Who are RA Medical Systems' major shareholders?

RA Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include Principal Financial Group Inc. (3.53%) and Bourne Lent Asset Management Inc. (1.53%). Company insiders that own RA Medical Systems stock include Andrew C Jackson, Dean Irwin, Jeffrey J Kraws and Martin Burstein. View institutional ownership trends for RA Medical Systems.

Which major investors are selling RA Medical Systems stock?

RMED stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc.. Company insiders that have sold RA Medical Systems company stock in the last year include Andrew C Jackson, Dean Irwin, Jeffrey J Kraws, and Martin Burstein. View insider buying and selling activity for RA Medical Systems.

Which major investors are buying RA Medical Systems stock?

RMED stock was acquired by a variety of institutional investors in the last quarter, including Bourne Lent Asset Management Inc.. View insider buying and selling activity for RA Medical Systems.

How do I buy shares of RA Medical Systems?

Shares of RMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RA Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $0.53.

How big of a company is RA Medical Systems?

RA Medical Systems has a market capitalization of $7.44 million and generates $7.20 million in revenue each year. The company earns $-56,960,000.00 in net income (profit) each year or ($4.33) on an earnings per share basis. RA Medical Systems employs 95 workers across the globe.

What is RA Medical Systems' official website?

The official website for RA Medical Systems is www.ramed.com.

How can I contact RA Medical Systems?

RA Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company can be reached via phone at 760-804-1648 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff